2.80
1.74%
-0.0496
IRIDEX Corp. stock is currently priced at $2.80, with a 24-hour trading volume of 16,348.
It has seen a -1.74% decreased in the last 24 hours and a -9.39% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $2.83 pivot point. If it approaches the $2.78 support level, significant changes may occur.
Previous Close:
$2.8496
Open:
$2.92
24h Volume:
16,348
Market Cap:
$45.51M
Revenue:
$51.87M
Net Income/Loss:
$-9.57M
P/E Ratio:
-5.8333
EPS:
-0.48
Net Cash Flow:
$-6.85M
1W Performance:
-2.44%
1M Performance:
-9.39%
6M Performance:
+19.15%
1Y Performance:
+24.44%
IRIDEX Corp. Stock (IRIX) Company Profile
Name
IRIDEX Corp.
Sector
Industry
Phone
650 940 4700
Address
1212 Terra Bella Avenue, Mountain View, CA
IRIDEX Corp. Stock (IRIX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-03-17 | Resumed | ROTH Capital | Buy |
Dec-21-16 | Initiated | ROTH Capital | Buy |
Jan-26-16 | Initiated | Singular Research | Buy |
Jan-03-07 | Initiated | First Albany | Buy |
IRIDEX Corp. Stock (IRIX) Latest News
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
Zacks Investment Research
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
GlobeNewswire Inc.
Zacks Industry Outlook Highlights MicroVision, Cutera and IRIDEX
Zacks Investment Research
3 Laser Systems Stocks to Watch in a Challenging Industry
Zacks Investment Research
IPG Photonics (IPGP) Q4 Earnings Miss Estimates
Zacks Investment Research
IRIDEX Corp. Stock (IRIX) Financials Data
IRIDEX Corp. (IRIX) Revenue 2024
IRIX reported a revenue (TTM) of $51.87 million for the quarter ending December 31, 2023, a -8.96% decline year-over-year.
IRIDEX Corp. (IRIX) Net Income 2024
IRIX net income (TTM) was -$9.57 million for the quarter ending December 31, 2023, a -26.81% decrease year-over-year.
IRIDEX Corp. (IRIX) Cash Flow 2024
IRIX recorded a free cash flow (TTM) of -$6.85 million for the quarter ending December 31, 2023, a +30.10% increase year-over-year.
IRIDEX Corp. (IRIX) Earnings per Share 2024
IRIX earnings per share (TTM) was -$0.59 for the quarter ending December 31, 2023, a -25.53% decline year-over-year.
About IRIDEX Corp.
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
Cap:
|
Volume (24h):